南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

OPRK1不足导致滋养层功能障碍与子痫前期发病机制相关性研究

OPRK1 insufficiency results in trophoblast dysfunction and correlates with preeclampsia pathogenesis

Yi Yuan, Weihong Zeng, Linlin Song, Chuanmei Qin, Yuan Zhang, Fan Wu, Yichi Xu, Yi Lin

Journal:JOURNAL OF REPRODUCTIVE IMMUNOLOGY

IF:3.5

DOI:10.1016/j.jri.2026.104923

PMID:

Published:2026-06-08

research field:分子生物学生殖医学信号转导妇产科学

Abstract

Aberrations in trophoblast proliferation, invasion and hypoxia adaptation are implicated in pregnancy-related complications. OPRK1, encoding the κ-opioid receptor 1, is a member of the G protein-coupled receptors. In this study, we observed a marked downregulation of OPRK1 in decidual-side placental tissue from patients with preeclampsia (PE). Using HTR-8/SVneo trophoblasts, we found that OPRK1 knockdown inhibited cells migration, induced G0/G1 arrest and increased apoptosis, while overexpression reversed these effects. OPRK1 knockdown suppressed PI3K/AKT signaling and epithelial-mesenchymal-transition related pathways. In a L-NAME-induced PE mouse model, the OPRK1 agonist U50488H administration ameliorated PE-related symptoms including hypertension, placental defects, and fetal growth restriction. Therefore, our data indicated that OPRK1 may represent a potential therapeutic target for PE, although further validation in preclinical models is needed.

本文使用的Yeasen产品

购物车
客服
转染试用